Willingness to pay for medications among patients with Rome IV Irritable Bowel Syndrome.
Vivek Chand GoodooryCho Ee NgChristopher J BlackAlexander Charles FordPublished in: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2022)
Patients with IBS are willing to pay for medications which improve IBS symptoms. Future studies should investigate the relative importance of medication pricing, efficacy, and side effect profile among individuals with IBS.